Dariusz Mirosław Kowalski (Dariusz Kowalski, Dariusz M Kowalski)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 35

Top Venues

Current oncology (Toronto, Ont.)

Cancers

Journal of clinical medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Centrum Onkologii-Instytut im Marii Skłodowskiej-Curie Warszawa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centrum Onkologii-Instytut im Marii Skłodowskiej-Curie Warszawa

Poland

MD, PhD, Ass Prof :: Lung Cancer and Chest Tumours

Publications

Dariusz Mirosław Kowalski, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Maciej Krzakowski
The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity. Translational lung cancer research 13 (6) (2024)
Dariusz Mirosław Kowalski, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Maciej Krzakowski
The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity. Translational lung cancer research 13 (6) (2024)
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom, Melina E Marmarelis, Rachel E Sanborn, James Chih-Hsin Yang, Baogang Liu, Thomas John, Bartomeu Massuti, Alexander I Spira, Se-Hoon Lee, Jialei Wang, Juan Li, Caigang Liu, Silvia Novello, Masashi Kondo, Motohiro Tamiya, Ernesto Korbenfeld, Mor Moskovitz, Ji-Youn Han, Mariam Alexander, Rohit Joshi, Enriqueta Felip Font, Pei-Jye Voon, Pongwut Danchaivijitr, Ping-Chih Hsu, Felipe José Silva Melo Cruz, Thomas Wehler, Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K Sabari, Angel Qin, Dariusz Mirosław Kowalski, Mehmet Ali Nahit Şendur, John Xie, Debopriya Ghosh, Ali A Alhadab, Nahor Haddish-Berhane, Pamela L Clemens, Patricia Lorenzini, Remy B Verheijen, Mohamed Gamil, Joshua M Bauml, Mahadi Baig, Antonio Passaro, null null
Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR -mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Aleksandra Piórek, Adam Płużański, Piotr Wiśniewski, Sylwia Tabor, Kinga Winiarczyk, Magdalena Knetki-Wroblewska, Dariusz Mirosław Kowalski, Maciej Krzakowski
Pulmonary Benign Metastasizing Leiomyoma in a Postmenopausal Woman: A Case Report and Review of the Literature. Diseases (Basel, Switzerland) 12 (8) (2024)
Niels Reinmuth, Oscar Juan Vidal, Dariusz Mirosław Kowalski, Maciej Bryl, Anna Kryzhanivska, David Vicente, Zsolt Horváth, Gabriella Gálffy, Eszter Csánky, Zsolt Pápai Székely, Ihor Vynnychenko, Jon Armstrong, Tapashi Dalvi, Mingchao Xie, Sonia Iyer, Yashaswi Shrestha, Haiyi Jiang, Igor Bondarenko
Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small-Cell Lung Cancer: The Phase II BALTIC Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Aleksandra Piórek, Adam Płużański, Piotr Wiśniewski, Sylwia Tabor, Kinga Winiarczyk, Magdalena Knetki-Wroblewska, Dariusz Mirosław Kowalski, Maciej Krzakowski
Pulmonary Benign Metastasizing Leiomyoma in a Postmenopausal Woman: A Case Report and Review of the Literature. Diseases (Basel, Switzerland) 12 (8) (2024)
Aleksandra Piórek, Adam Płużański, Piotr Wiśniewski, Sylwia Tabor, Kinga Winiarczyk, Magdalena Knetki-Wroblewska, Dariusz Mirosław Kowalski, Maciej Krzakowski
Pulmonary Benign Metastasizing Leiomyoma in a Postmenopausal Woman: A Case Report and Review of the Literature. Diseases (Basel, Switzerland) 12 (8) (2024)
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom, Melina E Marmarelis, Rachel E Sanborn, James Chih-Hsin Yang, Baogang Liu, Thomas John, Bartomeu Massuti, Alexander I Spira, Se-Hoon Lee, Jialei Wang, Juan Li, Caigang Liu, Silvia Novello, Masashi Kondo, Motohiro Tamiya, Ernesto Korbenfeld, Mor Moskovitz, Ji-Youn Han, Mariam Alexander, Rohit Joshi, Enriqueta Felip Font, Pei-Jye Voon, Pongwut Danchaivijitr, Ping-Chih Hsu, Felipe José Silva Melo Cruz, Thomas Wehler, Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K Sabari, Angel Qin, Dariusz Mirosław Kowalski, Mehmet Ali Nahit Şendur, John Xie, Debopriya Ghosh, Ali A Alhadab, Nahor Haddish-Berhane, Pamela L Clemens, Patricia Lorenzini, Remy B Verheijen, Mohamed Gamil, Joshua M Bauml, Mahadi Baig, Antonio Passaro, null null
Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR -mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda, Anna Janowicz-Żebrowska, Aleksandra Piórek, Magdalena Knetki-Wroblewska, Piotr Jaśkiewicz, Adam Płużański, Maciej Krzakowski, Dariusz Mirosław Kowalski
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy. Cancers 15 (4) (2023)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda, Anna Janowicz-Żebrowska, Aleksandra Piórek, Magdalena Knetki-Wroblewska, Piotr Jaśkiewicz, Adam Płużański, Maciej Krzakowski, Dariusz Mirosław Kowalski
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy. Cancers 15 (4) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Aleksandra Piórek, Adam Płużański, Kinga Winiarczyk, Magdalena Zaborowska-Szmi, Katarzyna Zajda, Dariusz Mirosław Kowalski, Maciej Krzakowski
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice. Journal of clinical medicine 12 (6) (2023)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Aleksandra Piórek, Adam Płużański, Kinga Winiarczyk, Magdalena Zaborowska-Szmi, Katarzyna Zajda, Dariusz Mirosław Kowalski, Maciej Krzakowski
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice. Journal of clinical medicine 12 (6) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Maciej Krzakowski, Dariusz Mirosław Kowalski
Savolitinib for non-small cell lung cancer. Drugs of today (Barcelona, Spain : 1998) 59 (1) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Magdalena Zaborowska-Szmi, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda, Anna Janowicz-Żebrowska, Aleksandra Piórek, Magdalena Knetki-Wroblewska, Piotr Jaśkiewicz, Adam Płużański, Maciej Krzakowski, Dariusz Mirosław Kowalski
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy. Cancers 15 (4) (2023)
Silvia Novello, Dariusz Mirosław Kowalski, Alexander Luft, Mahmut Gümüş, David Vicente, Julien Mazieres, Jerónimo Rafael Rodríguez-Cid, Ali Tafreshi, Ying Cheng, Ki Hyeong Lee, Alexander Golf, Shunichi Sugawara, Andrew G Robinson, Balazs Halmos, Erin Jensen, Paul Schwarzenberger, M Catherine Pietanza, Luis G Paz-Ares
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Aleksandra Piórek, Adam Płużański, Kinga Winiarczyk, Magdalena Zaborowska-Szmi, Katarzyna Zajda, Dariusz Mirosław Kowalski, Maciej Krzakowski
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice. Journal of clinical medicine 12 (6) (2023)
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmi, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda, Maciej Krzakowski, Dariusz Mirosław Kowalski
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (2) (2023)
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz Mirosław Kowalski, Adam Płużański, Tomasz Kubiatowski, Ewa Anna Kalinka
RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy. Cancers 14 (21) (2022)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Adam Płużański, Zofia Lewandowska, Andrzej Tysarowski, Hubert Pawlik, Dariusz Mirosław Kowalski, Maciej Krzakowski
Efficacy of Immunotherapy in Second-Line Treatment of KRAS -Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice. Current oncology (Toronto, Ont.) 30 (1) (2022)
Ryan J Hartmaier, Aleksandra A Markovets, Myung-Ju Ahn, Lecia V Sequist, Ji-Youn Han, Byoung Chul Cho, Helena Alexandra Yu, Sang-We Kim, James Chih-Hsin Yang, Jong Seok Lee, Wu-Chou Su, Dariusz Mirosław Kowalski, Sergey V Orlov, Song Ren, Paul Frewer, Xiaoling Ou, Darren Ae Cross, Nisha Kurian, Mireille Cantarini, Pasi A Janne
Osimertinib+Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor Mutated MET-Amplified Non-Small Cell Lung Cancer: TATTON. Cancer discovery (2022)
Magdalena Knetki-Wroblewska, Kamila Wojas-Krawczyk, Dariusz Mirosław Kowalski, Maciej Krzakowski
Non-Small-Cell Lung Cancer Patients with Coexistence of High PD-L1 Expression and RET Fusion-Which Path Should We Follow? Case Reports and Literature Review. Journal of clinical medicine 11 (6) (2022)
Gilberto de Castro Junior, Iveta Kudaba, Yi-Long Wu, Gilberto de Lima Lopes, Dariusz Mirosław Kowalski, Hande Z Turna, Christian Caglevic, Li Zhang, Boguslawa Karaszewska, Konstantin K Laktionov, Vichien Srimuninnimit, Igor Bondarenko, Kaoru Kubota, Rinee Mukherjee, Jianxin Lin, Fabricio Souza, Tony S K Mok, Byoung Chul Cho
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Adam Płużański, Zofia Lewandowska, Andrzej Tysarowski, Hubert Pawlik, Dariusz Mirosław Kowalski, Maciej Krzakowski
Efficacy of Immunotherapy in Second-Line Treatment of KRAS -Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice. Current oncology (Toronto, Ont.) 30 (1) (2022)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Adam Płużański, Zofia Lewandowska, Andrzej Tysarowski, Hubert Pawlik, Dariusz Mirosław Kowalski, Maciej Krzakowski
Efficacy of Immunotherapy in Second-Line Treatment of KRAS -Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice. Current oncology (Toronto, Ont.) 30 (1) (2022)
Aleksandra Piórek, Adam Płużański, Pawel P Teterycz, Dariusz Mirosław Kowalski, Maciej Krzakowski
Do We Need TNM for Tracheal Cancers? Analysis of a Large Retrospective Series of Tracheal Tumors. Cancers 14 (7) (2022)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Adam Płużański, Zofia Lewandowska, Andrzej Tysarowski, Hubert Pawlik, Dariusz Mirosław Kowalski, Maciej Krzakowski
Efficacy of Immunotherapy in Second-Line Treatment of KRAS -Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice. Current oncology (Toronto, Ont.) 30 (1) (2022)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Adam Płużański, Zofia Lewandowska, Andrzej Tysarowski, Hubert Pawlik, Dariusz Mirosław Kowalski, Maciej Krzakowski
Efficacy of Immunotherapy in Second-Line Treatment of KRAS -Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice. Current oncology (Toronto, Ont.) 30 (1) (2022)
Magdalena Knetki-Wroblewska, Sylwia Tabor, Adam Płużański, Zofia Lewandowska, Andrzej Tysarowski, Hubert Pawlik, Dariusz Mirosław Kowalski, Maciej Krzakowski
Efficacy of Immunotherapy in Second-Line Treatment of KRAS -Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice. Current oncology (Toronto, Ont.) 30 (1) (2022)
Magdalena Zaborowska-Szmit, Marta Olszyna-Serementa, Dariusz Mirosław Kowalski, Sebastian Szmit, Maciej Krzakowski
Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy. Cancers 13 (18) (2021)
Magdalena Knetki-Wroblewska, Dariusz Mirosław Kowalski, Maciej Krzakowski
Nivolumab for Previously Treated Patients with Non-Small-Cell Lung Cancer-Daily Practice versus Clinical Trials. Journal of clinical medicine 9 (7) (2020)

Dariusz Mirosław Kowalski.css-eqlu8i{font-size:small;padding-left:4px;} (Dariusz Kowalski, Dariusz M Kowalski)

Publication Activity (10 Years)

Top Topics

Top Venues

Dariusz Mirosław Kowalski (Dariusz Kowalski, Dariusz M Kowalski)